High cervical spinal cord stimulation for occipital neuralgia: a case series and literature review

• Authors: Pavlos Texakalidis, Emory University; Muhibullah S. Tora, Emory University; Purva Nagarajan, Emory University; Orion P. Keifer, Jr., Emory University; Nicholas Boulis, Emory University
• Journal Title: Journal of Pain Research
• Volume: Volume 12
• Publisher: Dove Medical Press | 2019-01-01, Pages 2547-2553
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.2147/JPR.S214314
• Subjects: Biology, Neuroscience
• Keywords: Science & Technology; Life Sciences & Biomedicine; Clinical Neurology; Neurosciences & Neurology; occipital neuralgia; spinal cord stimulation; neuromodulation; GIANT-CELL ARTERITIS; NERVE-STIMULATION; SONOGRAPHY

Abstract

Background: Occipital neuralgia (ON) is defined as paroxysmal pain in the distribution of the greater, lesser, and/or third occipital nerves. ON can be refractory to conservative management and minimally invasive interventions. Neuromodulatory procedures can potentially treat refractory ON and include occipital nerve stimulation and the sparsely reported high cervical spinal cord stimulation (SCS). Objective: To report our experience and conduct a systematic literature review of studies evaluating the effect of high cervical SCS as a treatment modality for refractory ON. Methods: A retrospective review of patients with refractory ON who underwent high cervical SCS was conducted. In addition, a systematic literature review was performed according to the PRISMA guidelines. Results: Five patients with refractory ON were treated with high cervical (C1-C3) SCS in our institution. Two out of five (40%) patients reported a successful trial stimulation (>50% pain reduction) and received permanent implantation. During the follow-up, the visual analog scale score decreased from 7.5 to 4 and from 6.5 to 5 in these patients. No complications were reported for any of the patients. The systematic literature review, identified two eligible studies, comprising 18 patients overall who underwent cervicomedullary junction SCS. Nine out of 18 patients (50%) had a successful trial and received permanent implantation. Conclusion: High cervical or cervicomedullary junction SCS is associated with a 40-50% successful trial rate in refractory ON. No major complications were noted during the followup. Future studies are needed to compare the different neurosurgical options, in order to identify the optimal treatment strategy for refractory ON.